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Summary
 
During 
 
ab
 
 thymocyte development, the clonotypic 
 
ab
 
–T cell receptor (TCR) is preceded by
sequentially expressed immature versions of the TCR–CD3 complex: the pre-TCR, contain-
ing a clonotypic TCR-
 
b
 
 chain and invariant pre-T
 
a
 
, is expressed on pre-T cells before rear-
rangement of the TCR-
 
a
 
 locus. Moreover, clonotype-independent CD3 complexes (CIC)
appear on pro-T cells before VDJ rearrangements of TCR-
 
b
 
 genes. The pre-TCR is known
to mediate TCR-
 
b
 
 selection, the prerequisite for maturation of CD4
 
2
 
8
 
2
 
 double negative
(DN) thymocytes to the CD4
 
1
 
8
 
1
 
 double positive stage. A developmental function of CIC has
so far not been delineated. In mice single deficient and double deficient for CD3
 
z
 
/
 
h
 
 and/or
p56
 
lck
 
, we observe a pronounced reduction in the proportions of CD25
 
1
 
 DN thymocytes that
express intracellular TCR-
 
b
 
 chains. TCR-
 
b
 
 transcripts are reduced in parallel with TCR-
 
b
 
polypeptide chains whereas no reduction in TCR-
 
b
 
 locus rearrangements could be detected.
Wild-type levels of TCR-
 
b
 
 transcripts and of cells expressing TCR-
 
b
 
 polypeptide chains are
induced by treatment with anti-CD3
 
e
 
 mAb. The data suggest that the initial expression of re-
arranged TCR-
 
b
 
 VDJ genes in pro-T cell to pre-T cell progression is dependent on CD3
complex signaling, and thus define a putative developmental function for CIC.
Key words: TCR-
 
b
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D
 
uring T cell ontogeny, the complete 
 
ab
 
-TCR first
appears on the cell surface during the CD4
 
1
 
8
 
1
 
 dou-
ble positive (DP)
 
1
 
 stage of thymocyte development, after
VDJ rearrangements of both the TCR-
 
b
 
 and the TCR-
 
a
 
gene loci. Its initial function is the screening of DP cells for
proper recognition of MHC–peptide complexes in the
thymic microenvironment, thus selecting the MHC-
restricted, self-tolerant repertoire of peripheral T lympho-
cytes (reviewed in references 1, 2). The mature 
 
ab
 
-TCR is
preceded by the pre-TCR, expressed on CD4
 
2
 
8
 
2
 
 double
negative (DN) thymocytes that have rearranged TCR-
 
b
 
VDJ genes and before rearrangement of the TCR-
 
a
 
 locus.
Accordingly, the pre-TCR consists of a TCR-
 
b
 
 chain, a
surrogate TCR-
 
a
 
 chain termed pre-T
 
a
 
, and components
of the CD3 complex. It serves as a screening device for
productive rearrangement of a TCR-
 
b
 
 VDJ gene, a pro-
cess termed TCR-
 
b
 
 selection. Successful DN cells survive,
proliferate, and mature to the DP stage (for review see ref-
erences 3–6).
Expression of the pre-TCR on the thymocyte surface is
preceded by expression of CD3 complexes that lack clono-
typic components, so-called clonotype-independent CD3
complexes (CIC). This has first been recognized in experi-
ments in which immature DN thymocytes were exposed
to anti-CD3
 
e
 
 mAb, either in thymic organ culture (7, 8) or
in vivo (9, 10). In mice genetically unable to generate a
TCR-
 
b
 
 chain (8–10), treatment with anti-CD3
 
e
 
 induced
most known pre-TCR–dependent developmental responses.
In wild-type (wt) mice treatment with anti-CD3
 
e
 
 induced
premature shutdown of TCR-
 
b
 
 gene rearrangement,
equivalent to allelic exclusion (7). The latter experiments
suggested that CD3
 
e
 
 is expressed at the surface of thy-
mocytes of wt mice before TCR-
 
b
 
 VDJ rearrangements
(3, 7). The biochemical composition of CIC has first been
studied by Wiest et al. (11) who reported the existence of
CD3
 
eg
 
 and CD3
 
ed
 
 dimers that are brought to the surface
of TCR-
 
b
 
 negative immature thymocytes together with
calnexin, due to a leaky endoplasmic reticulum retention
 
1
 
Abbreviations used in this paper:
 
 BrdU, 5-bromodeoxyuridine; CIC, clono-
type-independent CD3 complex; dd, double deficient; DN, double nega-
tive; DP, double positive; HPRT, hypoxanthine phosphoribosyltrans-
ferase; Lck, p56
 
lck
 
; RT, reverse transcription; RTOC, reaggregate thymic
organ culture; sd, single deficient; wt, wild-type.
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mechanism in these cells (12). The CD3
 
d
 
 chain is physi-
cally present in CIC (11) but not required for pre-TCR
function, as indicated by the undisturbed TCR-
 
b
 
 selection
in CD3
 
d
 
-deficient mutant mice (13). CD3
 
z
 
 is functionally
associated with the pre-TCR (14) but its involvement with
CIC has not been obvious (15). CD3
 
e
 
 cross-linking studies
have suggested a role for the src family protein tyrosine ki-
nase p56
 
lck
 
 (Lck) in CIC signaling (15).
A function for CIC in normal thymocyte differentiation
has so far not been recognized. On the contrary, the nature
of the block in thymic development in CD3
 
e
 
-deficient
mice (16) has argued against a functional role of CIC: the
DN stage of thymocyte development can be divided by the
marker antigens CD44 and CD25 into four consecutive
subsets: CD44
 
1
 
CD25
 
2
 
, CD44
 
1
 
CD25
 
1
 
, CD44
 
2
 
CD25
 
1
 
,
and CD44
 
2
 
CD25
 
2
 
 (17). TCR-
 
b
 
 locus VDJ rearrange-
ment begins during the CD44
 
1
 
CD25
 
1
 
 stage and peaks at
the CD44
 
2
 
CD25
 
1
 
 stage (18, 19). TCR-
 
b
 
 polypeptide
chains are first detected in CD44
 
2
 
CD25
 
1
 
 DN cells (20,
21). TCR-
 
b
 
 positive cells proceed to the CD44
 
2
 
CD25
 
2
 
stage and subsequently become DP cells (20–23). The
block in thymocyte development in CD3
 
e
 
-deficient mice
lies between the CD44
 
2
 
CD25
 
1
 
 and the CD44
 
2
 
CD25
 
2
 
stages and has thus been indistinguishable from that in mice
deficient for RAG1/2 or for several other components re-
quired for a functional pre-TCR (reviewed in reference
24). This has been taken as evidence against a functional
role of CD3 complexes before the expression of the TCR-
 
b
 
chain and the formation of the pre-TCR.
In this paper, we report experiments on several strains of
mutant mice with graded defects in CD3 complex signal-
ing, suggesting a possible functional role for CIC. In mice
deficient for Lck (25), or for CD3
 
z
 
/
 
h
 
 (26–28), the genera-
tion of up to 15% of the wt number of DP thymocytes sug-
gests residual pre-TCR/CD3 signaling activities. A drastic
further reduction in DP cells in mice double deficient for
CD3
 
z
 
/
 
h 
 
and Lck suggests a more pronounced impairment
in pre-TCR function with both defects combined. In addi-
tion, mice single deficient or double deficient (sd or dd, re-
spectively) for CD3
 
z
 
/
 
h 
 
and/or Lck have moderately or se-
verely reduced numbers, respectively, of DN thymocytes
with intracellular TCR-
 
b
 
 polypeptide chains. TCR-
 
b
 
 VDJ
transcripts are reduced in parallel with TCR-
 
b
 
 polypeptide
chains whereas no reduction in TCR-
 
b
 
 locus rearrange-
ments could be detected. Stimulation with anti-CD3
 
e
 
 mAb
restores TCR-
 
b
 
 expression in thymocytes of mice double
deficient for CD3
 
z
 
/
 
h 
 
and Lck to the wt level. The results
suggest that expression of rearranged TCR-
 
b
 
 VDJ genes in
pro-T cells requires signals from a functional CD3 com-
plex, possibly assigning a developmental function to CIC.
 
Materials and Methods
 
Mice.
 
BALB/c mice, mice deficient of p56
 
lck
 
 (25), and mice
deficient of CD3
 
z
 
/
 
h
 
 (28) were bred in the specific pathogen-free
animal facilities of the Max-Planck-Institute. The latter two
strains were back-crossed at least five times to C57Bl/6. Crosses
of the p56
 
lck
 
 and CD3
 
z
 
/h mutations were monitored by PCR
analysis of DNA isolated from tissue obtained by earpunching,
using primers described in the original papers (25, 28).
mAbs and Flow Cytometry. The following mAbs, unlabeled or
labeled with either FITC, phycoerythrin or biotin, were pur-
chased from PharMingen (San Diego, CA): anti-CD4 (H129.19),
anti-CD8 (53-6.7), anti-TCR-b (H57-597), anti-CD44 (IM7),
anti-Ly9.1 (30C7), and anti-CD3e (500A2). Anti-CD25 (5A2)
was purified and labeled with FITC in our own laboratory. Red-
670 coupled to streptavidin was used for B-labeled antibodies.
Thymocytes were preincubated with supernatant of anti-FcR
mAb 2.4G2 before analysis. Intracellular staining was done on
cells fixed with paraformaldehyde and permeabilized with Sapo-
nin (Sigma, Heidelberg, Germany) as previously described (7,
20). Controls for cell surface stainings employed isotype-matched
mAb labeled with the same fluorochrome; controls for intracellu-
lar stainings employed blocking with an excess of the same unla-
beled mAb. Three-color FCM analysis employed a FACScanÒ;
sorting employed a FACStarÒ plus (Becton Dickinson & Co.,
Sparks, MD).
Treatment with Anti-CD3e mAb. Mice were injected with 15
mg purified anti-CD3e mAb 500A2 i.p. and their thymi were an-
alyzed by FCM at various time points thereafter. To analyze the
degree of thymocyte proliferation after injection of anti-CD3e,
the mice were injected at the same time with 250 mg 5-bro-
modeoxyuridine (BrdU; Boehringer Mannheim GmbH, Mann-
heim, Germany) i.p., and the drinking water was supplemented
with 1 mg/ml BrdU. Thymocytes were analyzed for BrdU incor-
poration as previously described (21). Of note, cells were heated
to 958C for 10 min to melt DNA, before staining with anti-BrdU
mAb. BrdU staining by this procedure is stoichiometric, and al-
lows investigators to distinguish cells with incomplete labeling,
i.e., after 1 S phase, from cells with maximal labeling, i.e., after 2
or more S phases (21, 29). Cell cycle analyses employed DNA
staining with 7-amino-actinomycin D (7AAD; Sigma) and FCM
analysis according to the method described in Rabinovitch et al. (30).
Reaggregate Thymic Organ Culture. Reaggregate thymic organ
culture (RTOC) were set up essentially as previously described
(31, 32). To test the effect of anti-CD3e mAb on thymocytes in
RTOC, 1–2 3 105 thymocytes were incubated in suspension for
2 h with 10 mg/ml mAb 500A2, washed three times with culture
medium, reaggregated with an equal number of thymic stroma
cells, and incubated for 3 d. Thymic stroma cells were obtained
from BALB/c fetal thymi at day of gestation 15 by treatment of
thymic lobes for 5 d with desoxyguanine (31). Thymocytes de-
rived from the mutant mice used in this study were of C57Bl/6
background that are, in contrast to BALB/c, negative for the ge-
netic marker Ly9.1 (33). FCM analyses after 3 d of culture in-
cluded gating for Ly9.1 negative cells.
Analysis of TCR-b Gene Rearrangements by Semiquantitative
PCR. DNA was prepared from thymocytes as described (34).
DNA was amplified in 25 ml reaction buffer containing 0.1 mg
DNA, 0.5 mM 59 and 39 primers, 200 mM of each dNTP (Phar-
macia, Freiburg, Germany), and 0.2 U Supertaq (HT Biotechnol-
ogy, Cambridge, UK), for 31 cycles (40 s at 948C, 60 s at 638C,
120 s at 728C). Primers were 59 Db2, 59 Vb8, 39 Jb2 (35), and 59
Vb5 (22). DNA samples were adjusted to similar concentrations
according to the strength of the signals for the insulin gene that
displays as two PCR products using the following primers: 59
CCACCCAGGCTTTTGTCAA, 39 ATGCTGGTGCAGCAC-
TGATC. The insulin PCR was performed in serial dilutions (un-
diluted, 1:4, and 1:16). After adjustment of DNA concentrations,
TCR-b PCR reactions were also done in 1:4 dilution steps.1671 Würch et al.
PCR products were subjected to gel electrophoresis in Tris-ace-
tate-EDTA buffer with 1.6% agarose and visualized by staining
with ethidium bromide as described (35, 36).
Estimation of TCR-b VDJC mRNAs by Semiquantitative Reverse
Transcription PCR. Total RNA was isolated using TRISOLV
(Biotex, Houston, TX) as directed by the manufacturer. To elim-
inate remaining genomic DNA, RNA preparations were sub-
jected to DNAse I (Boehringer Mannheim GmbH) digestion for
20 min at 378C. Oligo(dt)-primed cDNA was prepared from to-
tal RNA using RNaseH-Reverse Transcriptase (Gibco, Eggen-
stein, Germany) according to the recommendations of the manu-
facturer. Concentrations of cDNAs were adjusted by competitive
PCR between hypoxanthine phosphoribosyltransferase (HPRT,
249 bp) and a known amount of a control fragment (200 bp) us-
ing the primers described in Keller et al. (37). PCR was per-
formed in a volume of 25 ml using 0.5 U SUPER TAQ and re-
agents obtained from HT Biotechnology. For reverse transcription
(RT)-PCR of Vb5DJCb and Vb8DJCb products we used oligo-
nucleotides and cycle conditions as previously described (35). 10
ml of the resulting amplified material was subjected to gel electro-
phoresis in Tris-borate-EDTA buffer with 1% agarose and visual-
ized by staining with ethidium bromide.
Results
Reduced Proportions of Cells with Intracellular TCR-b
Chains Among CD251 DN Thymocytes in Mice Single Defi-
cient and Double Deficient for CD3z/h and Lck. Previous re-
sults have shown that mice single deficient for CD3 z/h
(z-sd) or Lck (Lck-sd) generate z5–15% of the wt number
of DP cells (25–28). As shown by the data in Fig. 1 (top),
the development of DP thymocytes is virtually completely
blocked in mice double deficient of CD3z/h and Lck (z/
Lck-dd). As previously shown, CD25 is maintained on
some of the DP cells in the single deficient mice (24, 25). A
detailed characterization of the block in pre-TCR–depen-
dent thymic development in z/Lck-dd mice has recently
been reported (Würch, A., J. Biro, I. Falk, and K. Eich-
mann, manuscript submitted for publication).
This paper is concerned with events before the forma-
tion of the pre-TCR, i.e., with factors that control the ini-
tial expression of TCR-b VDJ genes. The experiments
were stimulated by the unexpected observation that total
DN thymocytes of single deficient and in particular of z/Lck-
dd mice contain reduced proportions of cells with intracel-
lular TCR-b chains (Fig. 1, middle). As previously shown,
thymocytes harboring intracellular TCR-b polypeptide
chains first appear among CD442CD251 DN cells (20,
21). Whereas typically 40–50% of CD442CD251 cells are
TCR-b1, this proportion increases to .90% in the
CD442CD252 subset, due to TCR-b selection. Accord-
ingly, with considerable individual variation, #50% of
the DN thymocytes of adult wt mice may consist of
CD442CD252 cells. In contrast, as the formation of this
subset is pre-TCR–dependent, it is drastically reduced in
single deficient mice and in z/Lck-dd mice (Fig. 1, top,
and Würch, A., J. Biro, I. Falk, and K. Eichmann, manu-
script submitted for publication). Therefore, we compared
TCR-b expression of wt and mutant mice by excluding
CD442CD252 DN cells from the analysis, i.e., by gating
on DN cells positive for CD44 and/or CD25 (Fig. 1, bot-
tom). For the sake of convenience, cells gated in this way
will be referred to as CD251 DN cells, accounting for
.85% of this subset in wt and mutant mice. In both kinds
of single deficient mice, the proportions of TCR-b1 cells
among CD251 DN cells are ,20% compared with .40%
in wt mice. A more pronounced reduction of TCR-b1
cells is seen in the CD251 DN cells of z/Lck-dd mice,
ranging from 4–10% in individual mice. In addition, the
intensity of intracellular TCR-b staining is decreased, par-
ticularly in thymocytes of z/Lck-dd mice. These results
suggest that mice with compromised CD3 signaling possess
Figure 1. Three-color flow cytomet-
ric analyses of total thymocytes of adult
wt, z-sd, Lck-sd, and z/Lck-dd mice:
first color, CD4/CD8; second color,
CD44/CD25; third color, intracellular
(IC) TCR-b. (Top) Two parameter dot
plots of CD4/CD8 vs. CD44/CD25;
(middle) single parameter histograms of
TCR-b IC (shaded profiles) in gated
CD4282 DN cells; (bottom) single pa-
rameter histograms for TCR-b IC
(shaded profiles) in gated DN CD441/
CD251 cells. Genotypes and absolute
numbers of total thymocytes are given
on top, percentages of subpopulations
are given within each panel. Negative
controls for intracellular TCR-b stain-
ings employed blocking with an excess
of the same, unlabeled mAb (bold open
profiles). The wt mouse was analyzed
separately so that differences in fluores-
cence intensities are experimentally de-
termined.1672 Expression of TCR-b VDJ Genes and CD3 Signaling
reduced numbers of TCR-b1 CD251 DN thymocytes.
The extent of the reduction appears to be proportional to
the severity of the defect in CD3 signaling.
Analyses of TCR-b Locus DJ and VDJ Rearrangements in
Thymocytes of Mice Single-deficient and Double-deficient for
CD3z/h and/or Lck. The reduced number of TCR-b1
CD251 DN cells in z/Lck-dd mice may in principle be
due to a reduced generation rate, a reduced proliferation
rate, or an increased death rate of cells in this subset, or any
combination of these factors. A reduced rate of generation
of TCR-b1 thymocytes in mice deficient in CD3 complex
signaling may be due to compromised TCR-b locus VDJ
rearrangement. Semiquantitative analyses of DJ and VDJ
rearrangements in purified CD251 DN thymocytes of wt,
z-sd, Lck-sd, and z/Lck-dd mice are shown in Fig. 2. If re-
duced TCR-b rearrangements were responsible for the
low numbers of TCR-b1 CD251 DN cells in single defi-
cient and z/Lck-dd mice, this should be reflected in weaker
PCR signals. In particular, signal intensities of z/Lck-dd thy-
mocytes should be 5–10-fold weaker than that of wt
CD251 DN thymocytes, i.e., shifted by at least one dilu-
tion step. The data do not support this possibility, as they
fail to reveal significant quantitative differences between
the four strains of mice. There are minor quantitative vari-
ations, but these vary between experiments and may reflect
individual and/or technical variability. Within the limits of
this semiquantitative method, TCR-b DJ and VDJ rear-
rangements appear to proceed normally in thymocytes of
mice deficient in CD3 complex signaling.
Induction of Expression of Intracellular TCR-b Polypeptide
Chains in Thymocytes of Mice Double-deficient for CD3z/h and
Lck by Anti-CD3e mAb. If the paucity of TCR-b1 DN
cells in single deficient and z/Lck-dd mice was in any way
related to the deficiency in CD3 signaling it should be pos-
sible to increase the number of TCR-b1 DN cells by stim-
ulating the thymocytes with anti-CD3e mAb. Previously
we and others have shown that treatment of thymocytes of
various pre-TCR mutant mice with anti-CD3e mAb leads
to thymocyte proliferation and differentiation to the DP
stage (8–10, 15, 38). Although in these previous experi-
ments no attempts were made to separate proliferation
from differentiation, it seemed desirable for the present ex-
periments to distinguish the putative anti-CD3e induced
differentiation to TCR-b1 cells from the expansion of
the preexisting TCR-b1 population through anti-CD3e
induced proliferation. If an increase in the size of the
TCR-b1 subset depended on proliferation, the paucity of
TCR-b1 cells would most likely be due to insufficient ex-
pansion. An increase in the size of the TCR-b1 subset in-
dependent of proliferation would support the possibility
that CD3-mediated signals were involved in the control of
TCR-b expression.
To distinguish these possibilities, we titrated the amounts
of anti-CD3e injected per z/Lck-dd mouse (data not
shown) and identified a low dose that induces differentia-
tion without increasing the spontaneous proliferation of
thymocytes. The absence of additional proliferation is doc-
umented in Fig. 3, which compares the BrdU incorpora-
tion into thymocytes of z/Lck-dd mice during 3 d, un-
treated or after injection of 15 mg anti-CD3e. We observe
three distinct populations in untreated mice: cells with
maximal BrdU labeling have passed two or more S phases,
cells with submaximal labeling have passed one S phase,
Figure 2. Analyses of TCR-b locus rearrangements by semiquantita-
tive PCR of sorted CD251 DN cells of adult wt, z-sd, Lck-sd, and z/Lck-
dd mice. DNA was adjusted to similar amounts according to the strength
of the insulin PCR signals from fourfold dilutions. DJ (Db2Jb2) and VDJ
(Vb5DJb2, Vb8DJb2) PCRs were done in fourfold dilutions of the ad-
justed DNA samples as indicated. Amplified materials were subjected to
gel electrophoresis in Tris-acetate-EDTA buffer with 1.6% agarose and
visualized by staining with ethidium bromide. In the DJ rearrangements,
the top band represents the germline configuration. The six bands under-
neath and in the VDJ rearrangements represent the Jb21-6 elements from
top to bottom.
Figure 3. BrdU incorporation
(shaded profiles) into thymocytes
of z/Lck-dd mice injected 3 d
previously with 250 mg BrdU
(top) or BrdU plus 15 mg anti-
CD3e mAb i.p. BrdU (1 mg/ml)
was included in the drinking wa-
ter of all injected mice. Total
thymocyte numbers given at the
top of each panel, percentages of
gated subpopulations within each
panel. Staining with anti-BrdU
mAb was done after heating of
the cells to melt DNA, allowing
stoichiometric labeling of DNA.
Controls (open profiles, bold) em-
ployed thymocytes from un-
treated mice subjected to the
same staining protocol.1673 Würch et al.
and cells without label have not divided. In mice injected
with anti-CD3e the vast majority of cells show homoge-
neous submaximal label. The data suggest that thymocytes
of untreated mice divide heterogeneously and asynchro-
nously with a mean division rate of approximately once per
3 d. Injection of 15 mg anti-CD3e synchronizes cell divi-
sion such that almost all of the cells divide once during the
3 d. Accordingly, total thymocyte numbers of injected
mice remain within the range observed for untreated mice.
Fig. 4 shows experiments in which z/Lck-dd mice were
injected with 15 mg anti-CD3e on day 0 and their thy-
mocytes analyzed for CD4 and CD8 and for intracellular
TCR-b on each of three subsequent days. The proportion
of TCR-b1 DN cells increases slightly but not significantly
above the range observed in untreated mice. However, be-
ginning with day 2 we observe the appearance of DP cells
containing increasing proportions of TCR-b1 cells, reach-
ing .80% on day 3. Since DP thymocytes on day 3 ac-
count for z50%, .40% of all thymocytes are now TCR-
b1. As virtually all cells have divided once during the 3 d,
this increased proportion of TCR-b1 cells cannot have
arisen by proliferation of the preexisting TCR-b1 popula-
tion. These data therefore suggest that cross-linking of
CD3e induces de novo expression of intracellular TCR-b
polypeptide chains in z/Lck-dd thymocytes.
From the data in Fig. 4 it appears that induction of
TCR-b expression by anti-CD3e in z/Lck-dd thymocytes
occurs mostly after the cells acquire the DP phenotype.
Since this would indicate a reversal of the physiological or-
der of events, it was of interest to test TCR-b induction by
anti-CD3e in subpopulations of DN thymocytes. As shown
in Fig. 5, untreated z/Lck-dd mice generate very few
CD442CD252 cells. However, TCR-b1 cells are enriched
in this population suggesting rudimentary TCR-b selec-
tion (Würch, A., J. Biro, I. Falk, K. Eichmann, manuscript
submitted for publication). The CD442CD252 population
increases rapidly on days 1 and 2 after anti-CD3e, i.e., be-
fore the appearance of significant numbers of DP cells
(compare to Fig. 4, data on the same individual mice).
These CD442CD252 DN cells contain enhanced propor-
tions of TCR-b1 cells, suggesting an induction of TCR-b
expression before acquisition of the DP stage, at least in a
proportion of cells. Nevertheless, little TCR-b induction is
seen in CD251 DN cells, suggesting that stimulation with
anti-CD3e induces TCR-b expression and subsequent dif-
ferentiation in rapid succession.
The experiment in Fig. 5 was complemented by DNA
staining in order to assess anti-CD3e induced alterations in
cell cycle in DN subpopulations, as well as putative apop-
totic effects. Thymocytes with subdiploid DNA content
are not detected in either untreated or treated mice, argu-
ing against the possibility that the observed effects are influ-
enced by massive cell death. The CD251 DN population
contains a small proportion of cells in S/G2/M that does
not vary after injection of anti-CD3e. The few CD442
CD252 cells in untreated z/Lck-dd mice contain more
than twice as many cells in S/G2/M, consistent with the
maintenance of limited TCR-b selection. Whereas the
number of CD442CD252 cells increases after injection of
anti-CD3e, a transient decrease in the proportion of CD442
CD252 cells in S/G2/M is seen on day 1. This may indi-
cate a transient cell cycle arrest, possibly the basis for the
anti-CD3e induced synchronization of proliferation sug-
gested by the data in Fig. 3. These data exclude the possi-
bility that injection of 15 mg anti-CD3e selectively stimu-
lates proliferation in the CD442CD252 population and
further support our conclusion that induction of TCR-b
expression in z/Lck-dd thymocytes is independent of pro-
liferation.
Even though z/Lck-dd mice generate minimal numbers
of peripheral CD3 positive cells (data not shown), it was
possible that in vivo injection of anti-CD3e mAb induces
Figure 4. Three-color FCM analyses of thy-
mocytes of z/Lck-dd mice before (day 0) or on
days 1, 2, and 3, after injection of 15 mg anti-
CD3e. Two parameter dot plots for CD4 and
CD8 are shown on top, single parameter histo-
grams of intracellular TCR-b expression
(shaded profiles) in gated DN and DP cells be-
low. Absolute thymocyte numbers given at the
top. Percentages of subpopulations indicated in
each frame. Negative controls for intracellular
stainings employed blocking with an excess of
the same, unlabeled mAb (bold profiles). DN
thymocytes have a slightly higher background
than DP thymocytes.1674 Expression of TCR-b VDJ Genes and CD3 Signaling
such cells to release cytokines that influence thymocytes
(39), possibly including the induction of TCR-b in the
thymus. To exclude this possibility, RTOC were set up
with z/Lck-dd thymocytes preincubated with anti-CD3e
or HIg for 2 h in suspension, then extensively washed, and
thereafter reaggregated with thymic stroma cells. As shown
in Fig. 6, after 3 d of RTOC such anti-CD3e–treated z/Lck-
dd thymocytes contain increased proportions of TCR-b1
cells, some of which have acquired CD4/CD8 expression.
Induction is less efficient than in vivo, most likely owing to
the brief exposure to the antibody. After RTOC, HIg-
treated (and untreated, not shown) thymocytes also have a
slightly enhanced TCR-b expression compared with ex
vivo cells, perhaps due to experimental handling. The data
suggest that TCR-b induction occurs by direct ligation of
CD3e on the surface of z/Lck-dd thymocytes.
TCR-b Expression in z/Lck-dd Thymocytes Is Controlled at
the mRNA Level. The levels of TCR-b VDJC mRNAs
were estimated by semiquantitative RT-PCR. Purified
DN and DP thymocytes of wt mice, DN cells of untreated
z/Lck-dd mice, and DN and DP thymocytes of z/Lck-dd
mice 3 d after injection of 15 mg anti-CD3e mAb, were
analyzed. The results in Fig. 7 reveal z10-fold lower Vb8
transcript levels in DN cells of z/Lck-dd mice compared
with wt DN cells. Slightly less pronounced differences are
seen for Vb5 transcripts. Injection of anti-CD3e induces
Vb8 and Vb5 mRNAs in DN cells nearly to wt levels, and
the DP cells induced in anti-CD3e treated z/Lck-dd mice
display wt levels of Vb8 and Vb5 mRNAs as well. The
data exclude the possibility that TCR-b expression in z/Lck-
dd mice is limited by some form of translational or post-
translational regulation. The good correlations between
levels of TCR-b VDJC mRNAs and the proportions of
cells expressing TCR-b polypeptide chains suggest that
Figure 5. Three-color FCM anal-
yses of thymocytes of z/Lck-dd mice
before (day 0) or on days 1, 2, and 3,
after injection of 15 mg anti-CD3e.
First color, CD44/CD25; second
color, intracellular TCR-b; third
color, DNA staining by 7AAD. Sin-
gle parameter histograms for total
thymocytes, and for gated CD441/
CD251, and CD442CD252 subsets
shown as indicated. Percentages of
CD442CD252 subsets (top, cross-
hatched), for TCR-b1 subsets (mid-
dle, shaded profiles; blocking controls
in bold), and cells in S/G2/M phase
of cell cycle (vertical hatch, bottom)
given in each frame. The mice in-
jected with anti-CD3e are the same
as those shown in Fig. 4, to facilitate
comparisons of the proportions of
DP cells (Fig. 4) and CD442CD252
cells on each day.
Figure 6. Three-color FCM analysis of thymocytes of z/Lck-dd mice
on day 3 of RTOC. On day 0, 1.2 3 105 thymocytes were incubated for
2 h in suspension culture with either 10 mg/ml of HIg or of anti-CD3e.
Thymocytes were extensively washed before reaggregation with 1.2 3
105 thymic stroma cells derived from day 15 BALB/c fetal thymic lobes
incubated for 5 d with desoxyguanine. First color, CD4/CD8; second
color, TCR-b IC; third color, Ly9.1. Two parameter dot plots are on
gated Ly9.1 negative cells, i.e., cells originating from z/Lck-dd mice.1675 Würch et al.
TCR-b expression in the thymus of z/Lck-dd mice is im-
paired at the mRNA level.
Discussion
The work presented in this paper was stimulated by the
phenotype of z/Lck-dd thymocytes which features a drastic
reduction in the numbers of TCR-b1 CD251 DN cells
and reduced TCR-b mRNA levels in this population.
This was unexpected as a pre-TCR–associated block in
thymocyte development should leave maturation up to the
TCR-b1 CD251 DN stage unperturbed. Experiments
were performed to link this phenotype to the defect in
CD3 signaling in z/Lck-dd mice, and to distinguish among
three nonmutually exclusive mechanisms that could ac-
count for this phenotype: a block in the generation, a block
in the proliferation, or a shorter lifetime of TCR-b1 cells.
A causal relationship between defective CD3 complex
signaling and the paucity of TCR-b1 cells in the mutant
mice is suggested by two lines of evidence. First, the extent
in reduction of TCR-b1 cells appears to reflect the severity
in the malfunction of the CD3 complex. Whereas mice
single-deficient for CD3z/h or for Lck possess z50% of
the wt number of TCR-b1 CD251 DN cells, the number
further drops to z10% in z/Lck-dd mice. It is not ex-
cluded that Lck and perhaps also the CD3z/h module may
have roles in other signaling pathways in immature thy-
mocytes, but the aggravation associated with the combined
deficiency strongly suggests the involvement of the CD3
complex. Second, the reduction in TCR-b1 cells including
TCR-b mRNA levels is corrected by treating z/Lck-dd
mice with anti-CD3e mAb. We excluded that the induc-
tion is mediated by long range in vivo effects, suggesting a
direct induction via CD3e on the thymocyte surface.
A defect in the generation of TCR-b1 cells in z/Lck-dd
mice would suggest a role for CD3 complexes before the
appearance of TCR-b chains, i.e., clonotype-independent
CD3 components. In contrast, a block in proliferation or a
shortened survival time of TCR-b1 cells would indicate
regulation by the pre-TCR–associated CD3 complex.
Therefore, it is important to discriminate between these al-
ternatives. Thymocytes of untreated z/Lck-dd mice prolif-
erate asynchronously such that about one-fourth divides
more than once, one-half divides just once, and one-fourth
does not divide during 3 d. The mean rate of division thus
appears to be once in 3 d, i.e., 3 d appears to be the mean
turnover period for thymocytes of untreated z/Lck-dd
mice. By titration of anti-CD3e we identified a low dose at
which proliferation and turnover appear to be synchro-
nized but not quantitatively altered. The subset of TCR-
b1 cells increases selectively z10-fold in z/Lck-dd mice
treated with this dose of anti-CD3e, whereas the total thy-
mic cellularity remains within the range of untreated mice.
Synchronization extends to the CD442CD252 cells, ex-
cluding selective proliferation in the induced cell popula-
tion. These data prove that the numerical increase of the
TCR-b1 subset after injection of anti-CD3e is indepen-
dent of proliferation. As a second possibility, the increased
proportion of the TCR-b1 subset after anti-CD3e may be
caused by a selective increase in longevity of the TCR-b1
cells in z/Lck-dd mice. As outlined above, cells turnover
once during 3 d so that full survival of all TCR-b1 cells
may result in an increase of merely twofold within 3 d after
injection of anti-CD3e. Thus, in order to account for the
observed proportion of .40% TCR-b1 cells after 3 d, the
numbers of TCR-b negative cells would have to be re-
duced at least fourfold, which would require substantial cell
death and result in a significant decrease in thymic cellular-
ity. Such a scenario is not consistent with our data which
therefore argues against the possibility that anti-CD3e in-
creases the number of TCR-b1 cells by increasing their
longevity. Assuming that the anti-CD3e treatment corrects
the physiological defects associated with CD3 malfunction,
these results argue against the possibility that the paucity of
TCR-b1 cells in z/Lck-dd mice is mainly caused by im-
paired proliferation or a reduced survival time. Hence, the
paucity of TCR-b1 cells in z/Lck-dd mice appears to be
mainly a consequence of the impaired generation of cells
that express intracellular TCR-b polypeptide chains.
Among the biosynthetic levels at which the generation
of TCR-b1 cells could be compromised we considered the
rearrangement of TCR-b VDJ genes and their expression
at the mRNA levels. An astounding fact in lymphopoiesis
has been the striking parallelism in the early phases of T and
B cell development, including the molecular design and the
selection processes mediated by the pre-TCR and the pre-
BCR (40). Recent data by Gong and Nussenzweig (41)
have shown that the Igb signaling component of the BCR
is required for rearrangement of the Igm chain genes in im-
mature B cells. In contrast, we could not detect evidence
Figure 7. Semiquantitative RT-PCR of Vb5DJCb and Vb8DJCb
mRNAs in isolated DN and DP thymocytes of wt mice, in DN cells of
untreated z/Lck-dd mice, and in DN and DP cells of z/Lck-dd mice in-
jected 3 d previously with anti-CD3e mAb. cDNAs were adjusted to
equal concentrations by competitive PCR between HPRT (249 bp) and
a control fragment (200 bp) added in known amounts. cDNA concentra-
tions equivalent to the standard amount of HPRT control fragment
shown on top. 10 ml of the resulting amplified material was subjected to
gel electrophoresis in Tris-borate-EDTA buffer with 1% agarose and vi-
sualized by staining with ethidium bromide.1676 Expression of TCR-b VDJ Genes and CD3 Signaling
for impaired TCR-b rearrangements in the CD3 signaling-
deficient mice studied in this report. It should be pointed
out that we used a semiquantitative method to estimate the
frequencies of TCR-b rearrangement, so that moderate
quantitative differences might have been missed. Neverthe-
less, using similar semiquantitative technology, we see
striking quantitative differences between TCR-b VDJC
mRNA levels of wt and z/Lck-dd mice. Indeed, the
mRNA levels fully account for the differences in the pro-
portions of TCR-b1 cells in wt and z/Lck-dd mice.
Therefore, we suggest that the paucity of TCR-b1 cells in
z/Lck-dd mice is predominantly caused by a block in the
expression of rearranged TCR-b VDJ genes at the mRNA
level. So far we do not know whether regulation takes
place at a transcriptional or posttranscriptional level. Other
examples for a control of mRNA levels by CD3 signaling
in immature thymocytes include the RAG genes (42) and
germline transcripts of TCR-b (43) and TCR-a genes
(42).
It cannot be excluded that TCR-b chains are expressed
in most z/Lck-dd thymocytes at a level below detection by
intracellular staining. If this were the case, a role for the
pre-TCR in TCR-b expression could be rescued by as-
suming that a low basal level of TCR-b chains is synthe-
tized CD3-independently, giving rise to the formation of a
few pre-TCR complexes on the cell surface; subsequent
full TCR-b expression requires positive feedback by sig-
naling through the pre-TCR. In the absence of experimen-
tal support for such a scenario, we think that a more plausi-
ble interpretation of the present experiments is that the
CD3-dependent signals inducing TCR-b expression in
immature thymocytes are generated by CIC. CIC may thus
represent developmentally relevant CD3 complexes. As
CIC are expressed on thymocytes at the pro-T cell stage
we suggest the term pro-TCR, in analogy to the pre-
TCR. It remains to be elucidated in which way the pro-
TCR generates the signals required for TCR-b expression.
Speculations with regard to a ligand for the pre-TCR have
been discussed at length (40, 44) and the arguments, which
apply to the pro-TCR as well, shall not be repeated here.
At present the evidence appears to favor the possibility that
the immature forms of the TCR may generate signals
without a requirement for ligand recognition (45). Addi-
tional open questions include whether the pro-TCR con-
tains other components, in addition to those of the CD3
complex. An obvious candidate is pre-Ta (46), which has
been shown to be present at the mRNA level in pro-T
cells (47). A surrogate TCR-b chain may also be consid-
ered, as well as other proteins that have been found associ-
ated with the pre-TCR (48, 49).
In z/Lck-dd mice, a small residual CD3 signaling activity
is suggested by a small amount of pre-TCR–dependent
TCR-b selection spontaneously taking place. Recent work
on the characterization of mice double deficient for the src-
family protein tyrosine kinases Lck and Fyn has revealed
that both are involved in pre-TCR signaling (50, 51). Al-
though Lck seems to be part of the major pathway, Fyn can
partially replace Lck in its absence. Therefore, it is reason-
able to assume that the small residual CD3 signaling activ-
ity, as well as the activation of z/Lck-dd thymocytes by
anti-CD3e, is mediated by a cooperation between CD3e
and Fyn. Although this activity is insufficient for the gener-
ation of significant numbers of DP cells, it suffices to medi-
ate z10% of wt TCR-b expression. This finding indicates
a relatively low signaling requirement of TCR-b expres-
sion, and is consistent with a hypothesis in which successive
CD3-dependent steps in thymocyte development require
stepwise increasing signal intensities (52). It would be of in-
terest to study TCR-b expression in the thymus of mice in
which CD3 signaling is totally abolished.
What could be the biological purpose of a mechanism
that places TCR-b expression under the control of CD3
signaling? Optimal CD3 signaling requires expression of
multiple gene products including those of the CD3 com-
plex proper, downstream elements such as protein tyrosine
kinases of the src and syk families, as well as other known
and unknown factors. It is possible that the correct timing
in the activation of the large array of involved genes is not
free of errors. Placing TCR-b expression under the control
of CD3 signaling would provide an elegant mechanism for
a selective recruitment of signal-competent cells into the
developmental process, and for excluding signal-incompe-
tent cells from this process. Future studies will have to test
the hypothesis that ordered and complete expression of the
CD3-associated signaling system may be error prone. If so,
TCR-b expression would define a novel CD3-dependent
checkpoint in early thymocyte development, preceding
TCR-b selection.
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